手術ロボット市場規模、シェア、動向、2030年までの世界予測

世界の手術ロボット市場は、予測期間中に年平均成長率（CAGR）14.7%で成長し、2025年の136億9,000万米ドルから2030年には271億4,000万米ドルに達すると予測されています。

医療提供者が手術精度の向上、患者転帰の改善、低侵襲手術の支援を目的としてロボット支援システムを導入するケースが増えていることから、手術ロボット市場は力強い成長を遂げています。迅速な回復、合併症の軽減、入院期間の短縮といったニーズの高まりを受け、病院は様々な専門分野においてロボット技術への投資を進めています。画像診断技術の向上、AIを活用したガイダンス、ロボットプラットフォームの小型化といった技術の継続的な進歩は、ロボット手術の臨床応用を拡大させています。同時に、外科医の研修プログラムの拡充、支援的な診療報酬制度の整備、そして患者の意識向上も導入を加速させています。これらの要因が相まって市場を牽引し、ロボット支援手術の世界的な普及を促進しています。

調査範囲：

本レポートは、手術ロボット市場を分析し、提供内容、用途、エンドユーザー、地域といった様々なセグメントに基づいて、市場規模と将来の成長可能性を推定することを目的としています。また、主要企業の競合分析に加え、企業概要、サービス内容、最近の動向、主要な市場戦略についても解説しています。

レポートを購入する理由

本レポートは、手術ロボット市場全体の収益数値に最も近い情報を提供し、市場リーダー企業や新規参入企業にとって役立ちます。本レポートは、関係者が競争環境を理解し、ビジネスポジショニングを改善し、適切な市場開拓戦略を策定するための貴重な洞察を得るのに役立ちます。また、主要な市場牽引要因、制約要因、課題、そして機会に関する情報を提供することで、市場の動向を把握するのにも役立ちます。

本レポートでは、以下の点について洞察を提供します。

主要な推進要因（ロボット支援手術の利点、技術の進歩、保険償還シナリオの改善、手術ロボットの導入拡大、医療ロボット研究への資金提供増加）、制約要因（ロボットシステムの高コスト）、機会（外来手術センター（ASC）への普及拡大と新興市場における成長機会）、課題（手術ミス）の分析。

• 市場浸透：世界の手術ロボット市場における主要企業が提供する製品に関する詳細な情報が含まれています。本レポートは、提供内容、用途、エンドユーザー、地域別に様々なセグメントを網羅しています。
• 製品の強化／イノベーション：世界の手術ロボット市場における新製品の発売と予想されるトレンドに関する包括的な詳細情報を提供します。
• 市場開発：提供内容、用途、エンドユーザー、地域別に、収益性の高い成長市場に関する詳細な知識と分析を提供します。
• 市場の多様化：世界の手術ロボット市場における新製品、拡大市場、現在の進歩、投資に関する包括的な情報を提供します。
• 競合評価：世界の外科用ロボット市場における主要競合他社の市場シェア、成長計画、製品提供、および能力に関する徹底的な評価を提供します。

Report Description

The global surgical robots market is projected to reach USD 27.14 billion by 2030 from USD 13.69 billion in 2025, at a CAGR of 14.7% during the forecast period.

The surgical robots market is experiencing strong growth as healthcare providers increasingly adopt robotic-assisted systems to enhance surgical precision, improve patient outcomes, and support minimally invasive procedures. The rising demand for faster recovery, reduced complications, and shorter hospital stays is driving hospitals to invest in robotics across multiple specialties. Continuous technological advancements, such as improved imaging, AI-driven guidance, and more compact robotic platforms, are expanding the clinical applications of robotic surgery. At the same time, the growth of surgeon training programs, supportive reimbursement structures, and increased patient awareness are accelerating adoption. Together, these factors are pushing the market forward and broadening the global footprint of robotic-assisted surgery.

“By offering, the instruments & accessories segment held the largest market share in 2024.”

The instruments & accessories segment accounts for the largest share of the surgical robots market because these components are required for every robotic procedure, creating steady and recurring demand. While robotic systems are a one-time capital investment, instruments such as staplers, scissors, graspers, energy devices, and other consumables must be replaced after a limited number of uses, ensuring continuous utilization and revenue. Accessories, such as vision tools, ports, and trocars, are also essential for system functionality and require frequent replenishment. As robotic procedure volumes continue to rise and hospitals expand their robotic programs, the consumption of instruments and accessories grows proportionally, making this segment the most significant contributor to overall market revenue.

“By end user, the hospitals & clinics segment accounted for the largest market share in 2024.”

Hospitals & clinics dominate the surgical robots market because they are the primary locations where surgeries are performed and have the necessary facilities, financial resources, and trained personnel to adopt robotic technologies. These institutions invest in robotics to improve surgical precision, enhance patient outcomes, and streamline clinical workflows. Favorable reimbursement policies for minimally invasive procedures further support their adoption of robotic systems. Additionally, most surgeons undergo robotic training within hospital environments, which increases utilization. With growing patient expectations for advanced, minimally invasive care, hospitals & clinics continue to be the largest and most influential end users in the market.

“The US is expected to grow at the highest CAGR during the forecast period.”

The US is expected to grow at the highest CAGR within the North American surgical robots market due to its strong focus on adopting advanced medical technologies, rapid expansion of robotic-assisted surgical programs, and continuous investments in hospital infrastructure. The country benefits from a large base of trained surgeons, extensive clinical research activity, and high patient demand for minimally invasive procedures, all of which accelerate the uptake of robotic platforms. Favorable reimbursement policies, a strong presence of leading robotic surgery manufacturers, and ongoing product innovations further support growth. Additionally, the US healthcare system’s emphasis on improving patient outcomes, reducing hospital stays, and enhancing surgical precision continues to drive faster adoption of surgical robots compared to other countries in the region.

A breakdown of the primary participants (supply side) for the surgical robots market referred to in this report is provided below:

• By Company Type: Tier 1 (35%), Tier 2 (40%), and Tier 3 (25%)
• By Designation: C-level Executives (45%), Director-level Executives (35%), and Others (20%)
• By Region: North America (27%), Europe (25%), Asia Pacific (30%), Latin America (8%), and the Middle East & Africa (10%)

Prominent players in the surgical robots market are Intuitive Surgical (US), Stryker (US), Medtronic (Ireland), Smith+Nephew (UK), Zimmer Biomet (US), Asensus Surgical (US), Siemens Healthineers (Germany), CMR Surgical (UK), Johnson & Johnson (US), and Renishaw Plc (UK).

Research Coverage:

The report analyzes the surgical robots market and aims at estimating the market size and future growth potential of this market based on various segments such as offering, application, end user, and region. The report also includes a competitive analysis of the key players in this market along with their company profiles, service offerings, recent developments, and key market strategies.

Reasons to Buy the Report

The report will help market leaders/new entrants in this market with information on the closest approximations of the revenue numbers for the overall surgical robots market. This report will help stakeholders understand the competitive landscape and gain valuable insights to better position their businesses and plan suitable go-to-market strategies. The report also helps stakeholders understand the pulse of the market, providing them with information on key market drivers, restraints, challenges, and opportunities.

This report provides insights into the following pointers:

Analysis of key drivers (advantages of robot-assisted surgery, technological advancements, improving reimbursement scenario, increasing adoption of surgical robots, and increasing funding for medical robot research), restraints (high cost of robotic systems), opportunities (increasing penetration of surgical robots in ASCs and growth opportunities in emerging markets), and challenges (surgical errors).

• Market Penetration: It includes extensive information on products offered by the major players in the global surgical robots market. The report includes various segments by offering, application, end user, and region.
• Product Enhancement/Innovation: Comprehensive details about new product launches and anticipated trends in the global surgical robots market.
• Market Development: Thorough knowledge and analysis of the profitable rising markets by offering, application, end user, and region.
• Market Diversification: Comprehensive information about newly launched products, expanding markets, current advancements, and investments in the global surgical robots market.
• Competitive Assessment: Thorough evaluation of the market shares, growth plans, offerings of products, and capacities of the major competitors in the global surgical robots market.

Table of Contents

1 INTRODUCTION 26
1.1 STUDY OBJECTIVES 26
1.2 MARKET DEFINITION 26
1.3 STUDY SCOPE 27
1.3.1 MARKET SEGMENTATION & REGIONAL SCOPE 27
1.3.2 INCLUSIONS & EXCLUSIONS 28
1.3.3 YEARS CONSIDERED 28
1.3.4 CURRENCY CONSIDERED 28
1.4 STAKEHOLDERS 29
1.5 SUMMARY OF CHANGES 29
2 EXECUTIVE SUMMARY 31
2.1 KEY INSIGHTS & MARKET HIGHLIGHTS 31
2.2 KEY MARKET PARTICIPANTS: INSIGHTS & DEVELOPMENTS 32
2.3 DISRUPTIVE TRENDS SHAPING MARKET GROWTH 33
2.4 HIGH-GROWTH SEGMENTS & EMERGING FRONTIERS 34
2.5 SNAPSHOT: GLOBAL MARKET SIZE, GROWTH RATE, AND FORECAST 35
3 MARKET OVERVIEW 36
3.1 INTRODUCTION 36
3.1.1 DRIVERS 37
3.1.1.1 Advantages of robot-assisted minimally invasive surgeries 37
3.1.1.2 Technological advancements in surgical robots 37
3.1.1.3 Improving reimbursement scenario for surgical robots 38
3.1.1.4 Increasing adoption of surgical robots in modern surgeries 39
3.1.1.5 Increasing funding for medical robot research 39
3.1.2 RESTRAINTS 40
3.1.2.1 High cost of robotic systems 40
3.1.3 OPPORTUNITIES 40
3.1.3.1 Increasing penetration of surgical robots in outpatient settings 40
3.1.3.2 High growth opportunities in emerging economies 41
3.1.4 CHALLENGES 42
3.1.4.1 Rising number of surgical errors in global healthcare systems 42
3.2 UNMET NEEDS & WHITE SPACES 43
3.2.1 UNMET NEEDS IN SURGICAL ROBOTS MARKET 43
3.2.2 WHITE SPACE OPPORTUNITIES 44
3.3 INTERCONNECTED MARKETS AND CROSS-SECTOR OPPORTUNITIES 45
3.3.1 INTERCONNECTED MARKETS 45
3.3.2 CROSS-SECTOR OPPORTUNITIES 46
3.4 STRATEGIC MOVES BY TIER-1/2/3 PLAYERS 47
4 INDUSTRY TRENDS 48
4.1 PORTER’S FIVE FORCES ANALYSIS 48
4.1.1 THREAT OF NEW ENTRANTS 49
4.1.2 THREAT OF SUBSTITUTES 49
4.1.3 BARGAINING POWER OF SUPPLIERS 49
4.1.4 BARGAINING POWER OF BUYERS 49
4.1.5 INTENSITY OF COMPETITIVE RIVALRY 49
4.2 MACROECONOMIC OUTLOOK 50
4.2.1 INTRODUCTION 50
4.2.2 GDP TRENDS AND FORECAST 50
4.2.3 TRENDS IN GLOBAL MINIMALLY INVASIVE SURGICAL INSTRUMENTS INDUSTRY 52
4.2.4 TRENDS IN GLOBAL MEDICAL ROBOTS INDUSTRY 52
4.3 SUPPLY CHAIN ANALYSIS 53
4.4 VALUE CHAIN ANALYSIS 54
4.5 ECOSYSTEM ANALYSIS 55
4.6 PRICING ANALYSIS 56
4.6.1 AVERAGE SELLING PRICE OF SURGICAL ROBOTIC APPLICATIONS,
BY KEY PLAYER, 2024 56
4.6.2 AVERAGE SELLING PRICE TREND OF SURGICAL ROBOTS, BY REGION,
2022–2024 56
4.7 TRADE DATA ANALYSIS 57
4.7.1 IMPORT DATA FOR HS CODE 901890 57
4.7.2 EXPORT DATA FOR HS CODE 901890 58
4.8 KEY CONFERENCES AND EVENTS, 2025–2026 58
4.9 TRENDS/DISRUPTIONS IMPACTING CUSTOMER’S BUSINESS 60
4.10 INVESTMENT AND FUNDING SCENARIO 61
4.11 CASE STUDY ANALYSIS 61
4.11.1 REVOLUTIONISING FUTURE OF SURGERY WITH HIGH-PRECISION ROBOTS 61
4.11.2 HUNJAN HOSPITAL DEPLOYS ORTHOPEDIC SURGICAL ROBOT FOR KNEE REPLACEMENT SURGERY 62
4.11.3 BIONAUT LABS CREATES REMOTE-CONTROLLED MICRO-ROBOTS
TO TARGET BRAIN DISEASES 62
4.12 IMPACT OF 2025 US TARIFF ON SURGICAL ROBOTS MARKET 63
4.12.1 KEY TARIFF RATES 64
4.12.2 PRICE IMPACT ANALYSIS 64
4.12.3 IMPACT ON COUNTRY/REGION 65
4.12.3.1 North America 65
4.12.3.1.1 US 65
4.12.3.2 Europe 65
4.12.3.3 Asia Pacific 65
4.12.4 IMPACT ON END-USE INDUSTRIES 65
5 TECHNOLOGICAL ADVANCEMENTS, AI-DRIVEN IMPACT, PATENTS, INNOVATIONS, AND FUTURE APPLICATIONS 66
5.1 KEY EMERGING TECHNOLOGIES 66
5.1.1 ROBOTIC ARMS AND INSTRUMENTS 66
5.1.2 ARTIFICIAL INTELLIGENCE (AI) AND MACHINE LEARNING (ML) 66
5.1.3 TELEPRESENCE 66
5.1.4 5G TECHNOLOGY 66
5.1.5 COMPLEMENTARY TECHNOLOGIES 67
5.1.5.1 Augmented reality (AR) and virtual reality (VR) 67
5.1.5.2 3D printing 67
5.2 TECHNOLOGY/PRODUCT ROADMAP 67
5.2.1 SHORT-TERM (2025–2027) | FOUNDATION & EARLY COMMERCIALIZATION 67
5.2.2 MID-TERM (2027–2030) | EXPANSION & STANDARDIZATION 68
5.2.3 LONG-TERM (2030–2035+) | MASS COMMERCIALIZATION & DISRUPTION 69
5.3 PATENT ANALYSIS 70
5.4 FUTURE APPLICATIONS OF SURGICAL ROBOTS 71
5.5 IMPACT OF AI/GEN AI ON SURGICAL ROBOTS MARKET 72
5.5.1 TOP USE CASES AND MARKET POTENTIAL 73
5.5.2 BEST PRACTICES IN SURGICAL ROBOTS PROCESSING 73
5.5.3 CASE STUDIES OF AI IMPLEMENTATION 74
5.5.4 INTERCONNECTED ADJACENT ECOSYSTEM AND IMPACT
ON MARKET PLAYERS 75
5.5.5 CLIENTS’ READINESS TO ADOPT GENERATIVE AI 76
6 REGULATORY LANDSCAPE 77
6.1 REGIONAL REGULATIONS AND COMPLIANCE 77
6.1.1 REGULATORY BODIES, GOVERNMENT AGENCIES,
AND OTHER ORGANIZATIONS 77
6.1.2 REGULATORY FRAMEWORK 78
6.1.2.1 North America 78
6.1.2.1.1 US 78
6.1.2.2 Europe 79
6.1.2.3 Asia Pacific 79
6.1.2.3.1 Japan 79
6.1.2.3.2 China 80
6.1.2.3.3 India 80
6.1.3 INDUSTRY STANDARDS 81
6.2 CERTIFICATIONS, LABELING, AND ECO-STANDARDS 82

7 CUSTOMER LANDSCAPE & BUYER BEHAVIOR 83
7.1 DECISION-MAKING PROCESS 83
7.2 KEY STAKEHOLDERS & BUYING EVALUATION CRITERIA 83
7.2.1 KEY STAKEHOLDERS IN BUYING PROCESS 83
7.2.2 KEY BUYING CRITERIA 84
7.3 ADOPTION BARRIERS & INTERNAL CHALLENGES 85
7.4 UNMET NEEDS FROM END-USE INDUSTRIES 85
7.5 MARKET PROFITABILITY 86
7.5.1 REVENUE POTENTIAL 86
7.5.2 COST DYNAMICS 86
7.5.3 MARGIN OPPORTUNITIES IN KEY APPLICATIONS 86
8 SURGICAL ROBOTS MARKET, BY OFFERING 87
8.1 INTRODUCTION 88
8.2 INSTRUMENTS & ACCESSORIES 89
8.2.1 NEED FOR RECURRENT PURCHASE OF INSTRUMENTS & ACCESSORIES TO DRIVE MARKET GROWTH 89
8.3 ROBOTIC SYSTEMS 90
8.3.1 LAPAROSCOPIC ROBOTIC SYSTEMS 92
8.3.1.1 Growing popularity of laparoscopic robotic surgeries to drive market 92
8.3.2 ORTHOPEDIC ROBOTIC SYSTEMS 94
8.3.2.1 Rising number of market players offering orthopedic robots to support market growth 94
8.3.3 NEUROSURGICAL ROBOTIC SYSTEMS 95
8.3.3.1 Better reproducibility, higher accuracy, and greater precision in long, narrow surgical corridors to support market growth 95
8.3.4 OTHER ROBOTIC SYSTEMS 97
8.4 SERVICES 98
8.4.1 ONGOING NEED FOR SERVICE CONTRACTS FOR FUNDAMENTAL OPERATIONS TO PROPEL MARKET GROWTH 98
9 SURGICAL ROBOTS MARKET, BY APPLICATION 99
9.1 INTRODUCTION 100
9.2 GENERAL SURGERY 100
9.2.1 GROWING PREFERENCE FOR ROBOT-ASSISTED GENERAL SURGICAL PROCEDURES TO DRIVE MARKET 100
9.3 GYNECOLOGICAL SURGERY 102
9.3.1 RISING NUMBER OF HYSTERECTOMIES TO INCREASE DEMAND FOR SURGICAL ROBOTS 102
9.4 ORTHOPEDIC SURGERY 103
9.4.1 GROWING PREFERENCE FOR KNEE RECONSTRUCTION PROCEDURES TO SUPPORT MARKET GROWTH 103

9.5 UROLOGICAL SURGERY 105
9.5.1 RISING PREVALENCE OF UROLOGICAL DISEASES TO FUEL
DEMAND FOR SURGICAL ROBOTS 105
9.6 NEUROSURGERY 106
9.6.1 INCREASING USE OF ROBOTIC TECHNOLOGIES IN NEUROSURGICAL PROCEDURES TO DRIVE MARKET 106
9.7 MICROSURGERY 108
9.7.1 RISING INTERSECTION OF MINIMALLY INVASIVE SURGERY AND SURGICAL ROBOTS TO SUPPORT MARKET GROWTH 108
9.8 OTOLOGICAL SURGERY 110
9.8.1 RISING PREVALENCE OF EAR-RELATED DISORDERS TO SPUR MARKET GROWTH 110
9.9 OTHER APPLICATIONS 111
10 SURGICAL ROBOTS MARKET, BY END USER 113
10.1 INTRODUCTION 114
10.2 HOSPITALS & CLINICS 114
10.2.1 INCREASING ROBOTIC-ASSISTED SURGERIES TO PROPEL MARKET GROWTH 114
10.3 AMBULATORY SURGERY CENTERS 116
10.3.1 GROWING PATIENT PREFERENCE FOR COST-EFFECTIVE TREATMENTS TO DRIVE MARKET GROWTH 116
11 SURGICAL ROBOTS MARKET, BY REGION 118
11.1 INTRODUCTION 119
11.2 NORTH AMERICA 120
11.2.1 US 123
11.2.1.1 US to dominate North American surgical robots market
during study period 123
11.2.2 CANADA 125
11.2.2.1 Increased adoption of surgical robots for gynecological surgeries and cancerous tumor removal to drive market 125
11.3 EUROPE 128
11.3.1 GERMANY 130
11.3.1.1 Favorable healthcare initiatives and large pool of stroke patients to spur market growth 130
11.3.2 UK 132
11.3.2.1 Rising investments in surgical robots to propel market growth 132
11.3.3 FRANCE 134
11.3.3.1 Favorable investments and high demand for surgical robotic systems to boost market growth 134
11.3.4 SPAIN 136
11.3.4.1 Increasing number of robotic-assisted surgical procedures and initiatives to fuel growth 136
11.3.5 ITALY 138
11.3.5.1 Increasing number of robotic surgical procedures to
propel market growth 138
11.3.6 REST OF EUROPE 140
11.4 ASIA PACIFIC 143
11.4.1 JAPAN 145
11.4.1.1 Favorable government initiatives to support adoption
of surgical robots 145
11.4.2 CHINA 147
11.4.2.1 Favorable government initiatives to boost market growth 147
11.4.3 INDIA 150
11.4.3.1 Rapid developments in healthcare infrastructure to
support market growth 150
11.4.4 AUSTRALIA 152
11.4.4.1 Increasing implementation and development of s
urgical robotic training programs to fuel market growth 152
11.4.5 SOUTH KOREA 154
11.4.5.1 Increasing installation of surgical robots and growing government investments to ensure steady market growth 154
11.4.6 REST OF ASIA PACIFIC 156
11.5 LATIN AMERICA 158
11.5.1 BRAZIL 160
11.5.1.1 Rising incidence of target diseases and growing healthcare expenditure to drive market 160
11.5.2 MEXICO 162
11.5.2.1 Growing emphasis on surgical robotics in healthcare to support market growth 162
11.5.3 REST OF LATIN AMERICA 164
11.6 MIDDLE EAST & AFRICA 167
11.6.1 GCC COUNTRIES 169
11.6.1.1 Robust healthcare industry and favorable government strategies to drive market 169
11.6.2 REST OF MIDDLE EAST & AFRICA 171
12 COMPETITIVE LANDSCAPE 174
12.1 INTRODUCTION 174
12.2 KEY PLAYER STRATEGIES/RIGHT TO WIN 174
12.2.1 OVERVIEW OF STRATEGIES ADOPTED BY PLAYERS IN SURGICAL ROBOTS MARKET 175
12.3 REVENUE ANALYSIS, 2020–2024 177
12.4 MARKET SHARE ANALYSIS, 2024 177
12.5 COMPANY EVALUATION MATRIX: KEY PLAYERS, 2024 181
12.5.1 STARS 181
12.5.2 EMERGING LEADERS 181
12.5.3 PERVASIVE PLAYERS 181
12.5.4 PARTICIPANTS 181
12.5.5 COMPANY FOOTPRINT: KEY PLAYERS, 2024 183
12.5.5.1 Company footprint 183
12.5.5.2 Region footprint 184
12.5.5.3 Offering footprint 185
12.5.5.4 Application footprint 186
12.5.5.5 End-user footprint 187
12.6 COMPANY EVALUATION MATRIX: STARTUPS/SMES, 2024 188
12.6.1 PROGRESSIVE COMPANIES 188
12.6.2 DYNAMIC COMPANIES 188
12.6.3 STARTING BLOCKS 188
12.6.4 RESPONSIVE COMPANIES 188
12.6.5 COMPETITIVE BENCHMARKING: STARTUPS/SMES, 2024 190
12.6.5.1 Detailed list of key startups/SMEs 190
12.6.5.2 Competitive benchmarking of key startups/SMEs 190
12.7 COMPANY VALUATION & FINANCIAL METRICS 191
12.7.1 FINANCIAL METRICS 191
12.7.2 COMPANY VALUATION 191
12.8 BRAND/PRODUCT COMPARISON 192
12.9 COMPETITIVE SCENARIO 193
12.9.1 PRODUCT/SERVICE LAUNCHES AND APPROVALS 193
12.9.2 DEALS 194
12.9.3 EXPANSIONS 195
13 COMPANY PROFILES 196
13.1 KEY PLAYERS 196
13.1.1 INTUITIVE SURGICAL OPERATIONS, INC. 196
13.1.1.1 Business overview 196
13.1.1.2 Products/Services/Solutions offered 197
13.1.1.3 Recent developments 198
13.1.1.3.1 Product approvals 198
13.1.1.3.2 Deals 199
13.1.1.4 MnM view 200
13.1.1.4.1 Right to win 200
13.1.1.4.2 Strategic choices 200
13.1.1.4.3 Weaknesses & competitive threats 200
13.1.2 STRYKER 201
13.1.2.1 Business overview 201
13.1.2.2 Products/Services/Solutions offered 202
13.1.2.3 Recent developments 203
13.1.2.3.1 Product launches 203
13.1.2.3.2 Deals 203
13.1.2.3.3 Expansions 204
13.1.2.4 MnM view 204
13.1.2.4.1 Right to win 204
13.1.2.4.2 Strategic choices 204
13.1.2.4.3 Weaknesses & competitive threats 204
13.1.3 ZIMMER BIOMET 205
13.1.3.1 Business overview 205
13.1.3.2 Products/Services/Solutions offered 206
13.1.3.3 Recent developments 207
13.1.3.3.1 Product approvals 207
13.1.3.3.2 Deals 207
13.1.3.3.3 Other developments 208
13.1.3.4 MnM view 208
13.1.3.4.1 Right to win 208
13.1.3.4.2 Strategic choices 208
13.1.3.4.3 Weaknesses & competitive threats 208
13.1.4 MEDTRONIC 209
13.1.4.1 Business overview 209
13.1.4.2 Products/Services/Solutions offered 210
13.1.4.3 Recent developments 211
13.1.4.3.1 Product approvals 211
13.1.4.3.2 Deals 211
13.1.4.3.3 Expansions 212
13.1.4.4 MnM view 212
13.1.4.4.1 Right to win 212
13.1.4.4.2 Strategic choices 213
13.1.4.4.3 Weaknesses & competitive threats 213
13.1.5 SMITH+NEPHEW 214
13.1.5.1 Business overview 214
13.1.5.2 Products/Services/Solutions offered 215
13.1.5.3 Recent developments 216
13.1.5.3.1 Product & service launches and enhancements 216
13.1.5.4 MnM view 216
13.1.5.4.1 Right to win 216
13.1.5.4.2 Strategic choices 216
13.1.5.4.3 Weaknesses & competitive threats 217
13.1.6 ASENSUS SURGICAL US, INC. 218
13.1.6.1 Business overview 218
13.1.6.2 Products/Services/Solutions offered 219
13.1.6.3 Recent developments 219
13.1.6.3.1 Product approvals 219
13.1.6.3.2 Deals 220

13.1.7 SIEMENS HEALTHINEERS AG 222
13.1.7.1 Business overview 222
13.1.7.2 Products/Services/Solutions offered 223
13.1.7.3 Recent developments 224
13.1.7.3.1 Deals 224
13.1.8 RENISHAW PLC 225
13.1.8.1 Business overview 225
13.1.8.2 Products/Services/Solutions offered 226
13.1.8.3 Recent developments 227
13.1.8.3.1 Product approvals 227
13.1.9 GLOBUS MEDICAL 228
13.1.9.1 Business overview 228
13.1.9.2 Products/Services/Solutions offered 229
13.1.9.3 Recent developments 230
13.1.9.3.1 Product approvals 230
13.1.10 JOHNSON & JOHNSON 231
13.1.10.1 Business overview 231
13.1.10.2 Products/Services/Solutions offered 232
13.1.10.3 Recent developments 233
13.1.10.3.1 Product approvals 233
13.1.11 CMR SURGICAL LTD. 234
13.1.11.1 Business overview 234
13.1.11.2 Products/Services/Solutions offered 234
13.1.11.3 Recent developments 235
13.1.11.3.1 Product approvals 235
13.1.11.3.2 Deals 235
13.1.11.3.3 Expansions 236
13.1.11.3.4 Other developments 236
13.1.12 THINK SURGICAL, INC. 237
13.1.12.1 Business overview 237
13.1.12.2 Products/Services/Solutions offered 237
13.1.12.3 Recent developments 238
13.1.12.3.1 Product approvals 238
13.1.12.3.2 Deals 238
13.1.13 CORIN GROUP 240
13.1.13.1 Business overview 240
13.1.13.2 Products/Services/Solutions offered 240
13.1.13.3 Recent developments 241
13.1.13.3.1 Product launches & approvals 241

13.1.14 MICROSURE 242
13.1.14.1 Business overview 242
13.1.14.2 Products/Services/Solutions offered 242
13.1.14.3 Recent developments 243
13.1.14.3.1 Other developments 243
13.1.15 AVATERAMEDICAL GMBH 244
13.1.15.1 Business overview 244
13.1.15.2 Products/Services/Solutions offered 244
13.1.16 MEDICAL MICROINSTRUMENTS, INC. 245
13.1.16.1 Business overview 245
13.1.16.2 Products/Services/Solutions offered 245
13.1.16.3 Recent developments 245
13.1.16.3.1 Product approvals 245
13.1.16.3.2 Deals 246
13.1.16.3.3 Other developments 246
13.1.17 MEDICAROID CORPORATION 247
13.1.17.1 Business overview 247
13.1.17.2 Products/Services/Solutions offered 247
13.1.17.3 Recent developments 248
13.1.17.3.1 Product approvals 248
13.1.17.3.2 Deals 248
13.1.18 BRAINLAB SE 249
13.1.18.1 Business overview 249
13.1.18.2 Products/Services/Solutions offered 249
13.1.18.3 Recent developments 250
13.1.18.3.1 Product approvals 250
13.1.18.3.2 Deals 250
13.1.19 ECENTIAL ROBOTICS 251
13.1.19.1 Business overview 251
13.1.19.2 Products/Services/Solutions offered 251
13.1.19.3 Recent developments 252
13.1.19.3.1 Product approvals 252
13.1.19.3.2 Deals 252
13.1.20 SS INNOVATIONS INTERNATIONAL, INC. 253
13.1.20.1 Business overview 253
13.1.20.2 Products/Services/Solutions offered 255
13.1.20.3 Products/Services/Solutions in pipeline 257
13.1.20.4 Recent developments 257
13.1.20.4.1 Product launches and approvals 257
13.1.20.5 MnM view 258
13.1.20.5.1 Right to win 258
13.1.20.5.2 Strategic choices 258
13.1.20.5.3 Weaknesses & competitive threats 258
13.2 OTHER PLAYERS 259
13.2.1 MONTERIS 259
13.2.2 MOMENTIS INNOVATIVE SURGERY 259
13.2.3 TINAVI MEDICAL TECHNOLOGIES CO., LTD. 260
13.2.4 DISTALMOTION SA 261
13.2.5 NOVUS SAĞLIK ÜRÜNLERI AR-GE DANIŞMANLIK (NOVUS ARGE) 262
14 RESEARCH METHODOLOGY 263
14.1 RESEARCH DATA 263
14.1.1 SECONDARY DATA 264
14.1.1.1 Key sources of secondary data 264
14.1.1.2 Key data from secondary sources 265
14.1.2 PRIMARY DATA 265
14.1.2.1 Key objectives of primary research 266
14.1.2.2 Key data from primary sources 266
14.1.2.3 Key industry insights 267
14.2 MARKET SIZE ESTIMATION 267
14.2.1 BOTTOM-UP APPROACH 267
14.2.2 TOP-DOWN APPROACH 268
14.2.3 BASE NUMBER ESTIMATION 268
14.2.3.1 Supply-side analysis (revenue share analysis) 268
14.2.3.2 Company presentations and primary interviews 270
14.3 MARKET FORECAST APPROACH 270
14.4 DATA TRIANGULATION 272
14.5 STUDY ASSUMPTIONS 274
14.5.1 MARKET SHARE ASSUMPTIONS 274
14.5.2 RESEARCH ASSUMPTIONS 274
14.6 FACTOR ANALYSIS 275
14.7 RISK ANALYSIS 275
14.8 RESEARCH LIMITATIONS 276
15 APPENDIX 277
15.1 DISCUSSION GUIDE 277
15.2 KNOWLEDGESTORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL 281
15.3 CUSTOMIZATION OPTIONS 283
15.4 RELATED REPORTS 283
15.5 AUTHOR DETAILS 284

LIST OF TABLES

TABLE 1 SURGICAL ROBOTS MARKET: INCLUSIONS & EXCLUSIONS 28
TABLE 2 STANDARD CURRENCY CONVERSION RATES 29
TABLE 3 SURGICAL ROBOTS MARKET: CURRENT UNMET NEEDS 44
TABLE 4 SURGICAL ROBOTS MARKET: PORTER’S FIVE FORCES 48
TABLE 5 GDP PERCENTAGE CHANGE, BY COUNTRY, 2021–2030 50
TABLE 6 AVERAGE SELLING PRICE OF SURGICAL ROBOTIC APPLICATIONS,
BY KEY PLAYER, 2024 (USD MILLION) 56
TABLE 7 AVERAGE PRICING TREND OF SURGICAL ROBOTS, BY REGION,
2022–2024 (USD MILLION) 56
TABLE 8 IMPORT DATA FOR HS CODE 901890, BY COUNTRY,
2020–2024 (USD THOUSAND) 57
TABLE 9 EXPORT DATA FOR HS CODE 901890, BY COUNTRY,
2020–2024 (USD THOUSAND) 58
TABLE 10 LIST OF KEY CONFERENCES AND EVENTS IN SURGICAL ROBOTS MARKET, JANUARY 2025–DECEMBER 2026 58
TABLE 11 CASE STUDY 1: REVOLUTIONISING FUTURE OF SURGERY WITH HIGH-PRECISION ROBOTS 61
TABLE 12 CASE STUDY 2: HUNJAN HOSPITAL DEPLOYS ORTHOPEDIC SURGICAL ROBOT FOR KNEE REPLACEMENT SURGERY 62
TABLE 13 CASE STUDY 3: BIONAUT LABS CREATES REMOTE-CONTROLLED MICRO-ROBOTS TO TARGET BRAIN DISEASES 62
TABLE 14 US ADJUSTED RECIPROCAL TARIFF RATES 64
TABLE 15 KEY PRODUCT-RELATED TARIFF EFFECTIVE FOR SURGICAL ROBOTS 64
TABLE 16 LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES,
AND OTHER ORGANIZATIONS 77
TABLE 17 US FDA: MEDICAL DEVICE CLASSIFICATION 78
TABLE 18 US: MEDICAL DEVICE REGULATORY APPROVAL PROCESS 78
TABLE 19 JAPAN: MEDICAL DEVICE CLASSIFICATION UNDER PMDA 79
TABLE 20 CHINA: CLASSIFICATION OF MEDICAL DEVICES 80
TABLE 21 GLOBAL STANDARDS IN SURGICAL ROBOTS MARKET 81
TABLE 22 CERTIFICATIONS, LABELING, AND ECO-STANDARDS IN SURGICAL ROBOTS MARKET 82
TABLE 23 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS FOR KEY END USERS 83
TABLE 24 KEY BUYING CRITERIA FOR KEY TWO END USERS 84
TABLE 25 UNMET NEEDS FROM END-USE INDUSTRIES IN SURGICAL ROBOTS MARKET 85
TABLE 26 SURGICAL ROBOTS MARKET, BY OFFERING, 2023–2030 (USD MILLION) 88
TABLE 27 SURGICAL ROBOTS MARKET, BY REGION, 2023–2030 (MILLION UNITS) 88
TABLE 28 SURGICAL ROBOT INSTRUMENTS & ACCESSORIES MARKET, BY COUNTRY,
2023–2030 (USD MILLION) 90
TABLE 29 SURGICAL ROBOTIC SYSTEMS MARKET, BY TYPE, 2023–2030 (USD MILLION) 91
TABLE 30 SURGICAL ROBOTIC SYSTEMS MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 92
TABLE 31 LAPAROSCOPIC ROBOTIC SYSTEMS MARKET, BY COUNTRY,
2023–2030 (USD MILLION) 93
TABLE 32 ORTHOPEDIC ROBOTIC SYSTEMS MARKET, BY COUNTRY,
2023–2030 (USD MILLION) 95
TABLE 33 NEUROSURGICAL ROBOTIC SYSTEMS MARKET, BY COUNTRY,
2023–2030 (USD MILLION) 96
TABLE 34 OTHER ROBOTIC SYSTEMS MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 97
TABLE 35 SURGICAL ROBOT SERVICES MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 98
TABLE 36 SURGICAL ROBOTS MARKET, BY APPLICATION, 2023–2030 (USD MILLION) 100
TABLE 37 SURGICAL ROBOTS MARKET FOR GENERAL SURGERY, BY COUNTRY,
2023–2030 (USD MILLION) 101
TABLE 38 SURGICAL ROBOTS MARKET FOR GYNECOLOGICAL SURGERY, BY COUNTRY, 2023–2030 (USD MILLION) 103
TABLE 39 SURGICAL ROBOTS MARKET FOR ORTHOPEDIC SURGERY, BY COUNTRY,
2023–2030 (USD MILLION) 104
TABLE 40 SURGICAL ROBOTS MARKET FOR UROLOGICAL SURGERY, BY COUNTRY,
2023–2030 (USD MILLION) 106
TABLE 41 SURGICAL ROBOTS MARKET FOR NEUROSURGERY, BY COUNTRY,
2023–2030 (USD MILLION) 107
TABLE 42 SURGICAL ROBOTS MARKET FOR MICROSURGERY, BY COUNTRY,
2023–2030 (USD MILLION) 109
TABLE 43 SURGICAL ROBOTS MARKET FOR OTOLOGICAL SURGERY, BY COUNTRY,
2023–2030 (USD MILLION) 111
TABLE 44 SURGICAL ROBOTS MARKET FOR OTHER APPLICATIONS, BY COUNTRY,
2023–2030 (USD MILLION) 112
TABLE 45 SURGICAL ROBOTS MARKET, BY END USER, 2023–2030 (USD MILLION) 114
TABLE 46 SURGICAL ROBOTS MARKET FOR HOSPITALS & CLINICS, BY COUNTRY,
2023–2030 (USD MILLION) 115
TABLE 47 SURGICAL ROBOTS MARKET FOR AMBULATORY SURGERY CENTERS, BY COUNTRY, 2023–2030 (USD MILLION) 117
TABLE 48 SURGICAL ROBOTS MARKET, BY REGION, 2023–2030 (USD MILLION) 120
TABLE 49 NORTH AMERICA: SURGICAL ROBOTS MARKET, BY COUNTRY,
2023–2030 (USD MILLION) 121
TABLE 50 NORTH AMERICA: SURGICAL ROBOTS MARKET, BY OFFERING,
2023–2030 (USD MILLION) 122
TABLE 51 NORTH AMERICA: SURGICAL ROBOTIC SYSTEMS MARKET, BY TYPE,
2023–2030 (USD MILLION) 122
TABLE 52 NORTH AMERICA: SURGICAL ROBOTS MARKET, BY APPLICATION,
2023–2030 (USD MILLION) 123
TABLE 53 NORTH AMERICA: SURGICAL ROBOTS MARKET, BY END USER,
2023–2030 (USD MILLION) 123
TABLE 54 US: SURGICAL ROBOTS MARKET, BY OFFERING, 2023–2030 (USD MILLION) 124
TABLE 55 US: SURGICAL ROBOTIC SYSTEMS MARKET, BY TYPE, 2023–2030 (USD MILLION) 124
TABLE 56 US: SURGICAL ROBOTS MARKET, BY APPLICATION, 2023–2030 (USD MILLION) 125
TABLE 57 US: SURGICAL ROBOTS MARKET, BY END USER, 2023–2030 (USD MILLION) 125
TABLE 58 CANADA: SURGICAL ROBOTS MARKET, BY OFFERING, 2023–2030 (USD MILLION) 126
TABLE 59 CANADA: SURGICAL ROBOTIC SYSTEMS MARKET, BY TYPE,
2023–2030 (USD MILLION) 127
TABLE 60 CANADA: SURGICAL ROBOTS MARKET, BY APPLICATION,
2023–2030 (USD MILLION) 127
TABLE 61 CANADA: SURGICAL ROBOTS MARKET, BY END USER, 2023–2030 (USD MILLION) 127
TABLE 62 EUROPE: SURGICAL ROBOTS MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 128
TABLE 63 EUROPE: SURGICAL ROBOTS MARKET, BY OFFERING, 2023–2030 (USD MILLION) 128
TABLE 64 EUROPE: SURGICAL ROBOTIC SYSTEMS MARKET, BY TYPE,
2023–2030 (USD MILLION) 129
TABLE 65 EUROPE: SURGICAL ROBOTS MARKET, BY APPLICATION,
2023–2030 (USD MILLION) 129
TABLE 66 EUROPE: SURGICAL ROBOTS MARKET, BY END USER, 2023–2030 (USD MILLION) 129
TABLE 67 GERMANY: SURGICAL ROBOTS MARKET, BY OFFERING, 2
023–2030 (USD MILLION) 131
TABLE 68 GERMANY: SURGICAL ROBOTIC SYSTEMS MARKET, BY TYPE,
2023–2030 (USD MILLION) 131
TABLE 69 GERMANY: SURGICAL ROBOTS MARKET, BY APPLICATION,
2023–2030 (USD MILLION) 132
TABLE 70 GERMANY: SURGICAL ROBOTS MARKET, BY END USER,
2023–2030 (USD MILLION) 132
TABLE 71 UK: SURGICAL ROBOTS MARKET, BY OFFERING, 2023–2030 (USD MILLION) 133
TABLE 72 UK: SURGICAL ROBOTIC SYSTEMS MARKET, BY TYPE, 2023–2030 (USD MILLION) 133
TABLE 73 UK: SURGICAL ROBOTS MARKET, BY APPLICATION, 2023–2030 (USD MILLION) 134
TABLE 74 UK: SURGICAL ROBOTS MARKET, BY END USER, 2023–2030 (USD MILLION) 134
TABLE 75 FRANCE: SURGICAL ROBOTS MARKET, BY OFFERING, 2023–2030 (USD MILLION) 135
TABLE 76 FRANCE: SURGICAL ROBOTIC SYSTEMS MARKET, BY TYPE,
2023–2030 (USD MILLION) 135
TABLE 77 FRANCE: SURGICAL ROBOTS MARKET, BY APPLICATION,
2023–2030 (USD MILLION) 136
TABLE 78 FRANCE: SURGICAL ROBOTS MARKET, BY END USER, 2023–2030 (USD MILLION) 136
TABLE 79 SPAIN: SURGICAL ROBOTS MARKET, BY OFFERING, 2023–2030 (USD MILLION) 137
TABLE 80 SPAIN: SURGICAL ROBOTIC SYSTEMS MARKET, BY TYPE,
2023–2030 (USD MILLION) 137
TABLE 81 SPAIN: SURGICAL ROBOTS MARKET, BY APPLICATION, 2023–2030 (USD MILLION) 138
TABLE 82 SPAIN: SURGICAL ROBOTS MARKET, BY END USER, 2023–2030 (USD MILLION) 138
TABLE 83 ITALY: SURGICAL ROBOTS MARKET, BY OFFERING, 2023–2030 (USD MILLION) 139
TABLE 84 ITALY: SURGICAL ROBOTIC SYSTEMS MARKET, BY TYPE,
2023–2030 (USD MILLION) 139
TABLE 85 ITALY: SURGICAL ROBOTS MARKET, BY APPLICATION, 2023–2030 (USD MILLION) 140
TABLE 86 ITALY: SURGICAL ROBOTS MARKET, BY END USER, 2023–2030 (USD MILLION) 140
TABLE 87 REST OF EUROPE: SURGICAL ROBOTS MARKET, BY OFFERING,
2023–2030 (USD MILLION) 141
TABLE 88 REST OF EUROPE: SURGICAL ROBOTIC SYSTEMS MARKET,
BY TYPE, 2023–2030 (USD MILLION) 141
TABLE 89 REST OF EUROPE: SURGICAL ROBOTS MARKET, BY APPLICATION,
2023–2030 (USD MILLION) 142
TABLE 90 REST OF EUROPE: SURGICAL ROBOTS MARKET, BY END USER,
2023–2030 (USD MILLION) 142
TABLE 91 ASIA PACIFIC: SURGICAL ROBOTS MARKET, BY COUNTRY,
2023–2030 (USD MILLION) 144
TABLE 92 ASIA PACIFIC: SURGICAL ROBOTS MARKET, BY OFFERING,
2023–2030 (USD MILLION) 144
TABLE 93 ASIA PACIFIC: SURGICAL ROBOTIC SYSTEMS MARKET, BY TYPE,
2023–2030 (USD MILLION) 144
TABLE 94 ASIA PACIFIC: SURGICAL ROBOTS MARKET, BY APPLICATION,
2023–2030 (USD MILLION) 145
TABLE 95 ASIA PACIFIC: SURGICAL ROBOTS MARKET, BY END USER,
2023–2030 (USD MILLION) 145
TABLE 96 JAPAN: SURGICAL ROBOTS MARKET, BY OFFERING, 2023–2030 (USD MILLION) 146
TABLE 97 JAPAN: SURGICAL ROBOTIC SYSTEMS MARKET, BY TYPE,
2023–2030 (USD MILLION) 146
TABLE 98 JAPAN: SURGICAL ROBOTS MARKET, BY APPLICATION, 2023–2030 (USD MILLION) 147
TABLE 99 JAPAN: SURGICAL ROBOTS MARKET, BY END USER, 2023–2030 (USD MILLION) 147
TABLE 100 CHINA: SURGICAL ROBOTS MARKET, BY OFFERING, 2023–2030 (USD MILLION) 148
TABLE 101 CHINA: SURGICAL ROBOTIC SYSTEMS MARKET, BY TYPE,
2023–2030 (USD MILLION) 149
TABLE 102 CHINA: SURGICAL ROBOTS MARKET, BY APPLICATION, 2023–2030 (USD MILLION) 149
TABLE 103 CHINA: SURGICAL ROBOTS MARKET, BY END USER, 2023–2030 (USD MILLION) 149
TABLE 104 INDIA: SURGICAL ROBOTS MARKET, BY OFFERING, 2023–2030 (USD MILLION) 151
TABLE 105 INDIA: SURGICAL ROBOTIC SYSTEMS MARKET, BY TYPE,
2023–2030 (USD MILLION) 151
TABLE 106 INDIA: SURGICAL ROBOTS MARKET, BY APPLICATION, 2023–2030 (USD MILLION) 151
TABLE 107 INDIA: SURGICAL ROBOTS MARKET, BY END USER, 2023–2030 (USD MILLION) 152
TABLE 108 AUSTRALIA: SURGICAL ROBOTS MARKET, BY OFFERING,
2023–2030 (USD MILLION) 152
TABLE 109 AUSTRALIA: SURGICAL ROBOTIC SYSTEMS MARKET, BY TYPE,
2023–2030 (USD MILLION) 153
TABLE 110 AUSTRALIA: SURGICAL ROBOTS MARKET, BY APPLICATION,
2023–2030 (USD MILLION) 153
TABLE 111 AUSTRALIA: SURGICAL ROBOTS MARKET, BY END USER,
2023–2030 (USD MILLION) 153
TABLE 112 SOUTH KOREA: SURGICAL ROBOTS MARKET, BY OFFERING,
2023–2030 (USD MILLION) 154
TABLE 113 SOUTH KOREA: SURGICAL ROBOTIC SYSTEMS MARKET, BY TYPE,
2023–2030 (USD MILLION) 155
TABLE 114 SOUTH KOREA: SURGICAL ROBOTS MARKET, BY APPLICATION,
2023–2030 (USD MILLION) 155
TABLE 115 SOUTH KOREA: SURGICAL ROBOTS MARKET, BY END USER,
2023–2030 (USD MILLION) 156
TABLE 116 REST OF ASIA PACIFIC: SURGICAL ROBOTS MARKET, BY OFFERING,
2023–2030 (USD MILLION) 156
TABLE 117 REST OF ASIA PACIFIC: SURGICAL ROBOTIC SYSTEMS MARKET, BY TYPE,
2023–2030 (USD MILLION) 157
TABLE 118 REST OF ASIA PACIFIC: SURGICAL ROBOTS MARKET, BY APPLICATION,
2023–2030 (USD MILLION) 157
TABLE 119 REST OF ASIA PACIFIC: SURGICAL ROBOTS MARKET, BY END USER,
2023–2030 (USD MILLION) 158
TABLE 120 LATIN AMERICA: SURGICAL ROBOTS MARKET, BY COUNTRY,
2023–2030 (USD MILLION) 158
TABLE 121 LATIN AMERICA: SURGICAL ROBOTS MARKET, BY OFFERING,
2023–2030 (USD MILLION) 159
TABLE 122 LATIN AMERICA: SURGICAL ROBOTIC SYSTEMS MARKET, BY TYPE,
2023–2030 (USD MILLION) 159
TABLE 123 LATIN AMERICA: SURGICAL ROBOTS MARKET, BY APPLICATION,
2023–2030 (USD MILLION) 160
TABLE 124 LATIN AMERICA: SURGICAL ROBOTS MARKET, BY END USER,
2023–2030 (USD MILLION) 160
TABLE 125 BRAZIL: SURGICAL ROBOTS MARKET, BY OFFERING, 2023–2030 (USD MILLION) 161
TABLE 126 BRAZIL: SURGICAL ROBOTIC SYSTEMS MARKET, BY TYPE,
2023–2030 (USD MILLION) 161
TABLE 127 BRAZIL: SURGICAL ROBOTS MARKET, BY APPLICATION,
2023–2030 (USD MILLION) 162
TABLE 128 BRAZIL: SURGICAL ROBOTS MARKET, BY END USER, 2023–2030 (USD MILLION) 162
TABLE 129 MEXICO: SURGICAL ROBOTS MARKET, BY OFFERING, 2023–2030 (USD MILLION) 163
TABLE 130 MEXICO: SURGICAL ROBOTIC SYSTEMS MARKET, BY TYPE,
2023–2030 (USD MILLION) 163
TABLE 131 MEXICO: SURGICAL ROBOTS MARKET, BY APPLICATION,
2023–2030 (USD MILLION) 164
TABLE 132 MEXICO: SURGICAL ROBOTS MARKET, BY END USER, 2023–2030 (USD MILLION) 164
TABLE 133 REST OF LATIN AMERICA: SURGICAL ROBOTS MARKET, BY OFFERING,
2023–2030 (USD MILLION) 165
TABLE 134 REST OF LATIN AMERICA: SURGICAL ROBOTIC SYSTEMS MARKET, BY TYPE,
2023–2030 (USD MILLION) 165
TABLE 135 REST OF LATIN AMERICA: SURGICAL ROBOTS MARKET, BY APPLICATION,
2023–2030 (USD MILLION) 166
TABLE 136 REST OF LATIN AMERICA: SURGICAL ROBOTS MARKET, BY END USER,
2023–2030 (USD MILLION) 166
TABLE 137 MIDDLE EAST & AFRICA: SURGICAL ROBOTS MARKET, BY REGION,
2023–2030 (USD MILLION) 168
TABLE 138 MIDDLE EAST & AFRICA: SURGICAL ROBOTS MARKET, BY OFFERING,
2023–2030 (USD MILLION) 168
TABLE 139 MIDDLE EAST & AFRICA: SURGICAL ROBOTIC SYSTEMS MARKET, BY TYPE,
2023–2030 (USD MILLION) 168
TABLE 140 MIDDLE EAST & AFRICA: SURGICAL ROBOTS MARKET, BY APPLICATION,
2023–2030 (USD MILLION) 169
TABLE 141 MIDDLE EAST & AFRICA: SURGICAL ROBOTS MARKET, BY END USER,
2023–2030 (USD MILLION) 169
TABLE 142 GCC COUNTRIES: SURGICAL ROBOTS MARKET, BY OFFERING,
2023–2030 (USD MILLION) 170
TABLE 143 GCC COUNTRIES: SURGICAL ROBOTIC SYSTEMS MARKET, BY TYPE,
2023–2030 (USD MILLION) 170
TABLE 144 GCC COUNTRIES: SURGICAL ROBOTS MARKET, BY APPLICATION,
2023–2030 (USD MILLION) 171
TABLE 145 GCC COUNTRIES: SURGICAL ROBOTS MARKET, BY END USER,
2023–2030 (USD MILLION) 171
TABLE 146 REST OF MIDDLE EAST & AFRICA: SURGICAL ROBOTS MARKET, BY OFFERING, 2023–2030 (USD MILLION) 172
TABLE 147 REST OF MIDDLE EAST & AFRICA: SURGICAL ROBOTIC SYSTEMS MARKET,
BY TYPE, 2023–2030 (USD MILLION) 172
TABLE 148 REST OF MIDDLE EAST & AFRICA: SURGICAL ROBOTS MARKET, BY APPLICATION, 2023–2030 (USD MILLION) 173
TABLE 149 REST OF MIDDLE EAST & AFRICA: SURGICAL ROBOTS MARKET, BY END USER, 2023–2030 (USD MILLION) 173
TABLE 150 KEY STRATEGIES DEPLOYED BY MAJOR PLAYERS IN SURGICAL ROBOTS MARKET, JANUARY 2021–DECEMBER 2025 175
TABLE 151 SURGICAL ROBOTS MARKET: DEGREE OF COMPETITION 178
TABLE 152 SURGICAL ROBOTS MARKET: REGION FOOTPRINT 184
TABLE 153 SURGICAL ROBOTS MARKET: OFFERING FOOTPRINT 185
TABLE 154 SURGICAL ROBOTS MARKET: APPLICATION FOOTPRINT 186
TABLE 155 SURGICAL ROBOTS MARKET: END-USER FOOTPRINT 187
TABLE 156 SURGICAL ROBOTS MARKET: DETAILED LIST OF KEY STARTUPS/SME PLAYERS 190
TABLE 157 SURGICAL ROBOTS MARKET: COMPETITIVE BENCHMARKING OF KEY STARTUPS/SME PLAYERS, BY ROBOTIC SYSTEM TYPE AND REGION 190
TABLE 158 SURGICAL ROBOTS MARKET: PRODUCT/SERVICE LAUNCHES AND APPROVALS, JANUARY 2021–DECEMBER 2025 193
TABLE 159 SURGICAL ROBOTS MARKET: DEALS, JANUARY 2021–DECEMBER 2025 194
TABLE 160 SURGICAL ROBOTS MARKET: EXPANSIONS, JANUARY 2021–DECEMBER 2025 195
TABLE 161 INTUITIVE SURGICAL OPERATIONS, INC.: COMPANY OVERVIEW 196
TABLE 162 INTUITIVE SURGICAL OPERATIONS, INC.: PRODUCTS/SERVICES/SOLUTIONS OFFERED 197
TABLE 163 INTUITIVE SURGICALOPERATIONS, INC.: PRODUCT APPROVALS,
JANUARY 2021–DECEMBER 2025 198
TABLE 164 INTUITIVE SURGICAL OPERATIONS, INC.: DEALS, JANUARY 2021–DECEMBER 2025 199
TABLE 165 STRYKER: COMPANY OVERVIEW 201
TABLE 166 STRYKER: PRODUCTS/SERVICES/SOLUTIONS OFFERED 202
TABLE 167 STRYKER: PRODUCT LAUNCHES, JANUARY 2021–DECEMBER 2025 203
TABLE 168 STRYKER: DEALS, JANUARY 2021–DECEMBER 2025 203
TABLE 169 STRYKER: EXPANSIONS, JANUARY 2021–DECEMBER 2025 204
TABLE 170 ZIMMER BIOMET: COMPANY OVERVIEW 205
TABLE 171 ZIMMER BIOMET: PRODUCTS/SERVICES/SOLUTIONS OFFERED 206
TABLE 172 ZIMMER BIOMET: PRODUCT APPROVALS, JANUARY 2021–DECEMBER 2025 207
TABLE 173 ZIMMER BIOMET: DEALS, JANUARY 2021–DECEMBER 2025 207
TABLE 174 ZIMMER BIOMET: OTHER DEVELOPMENTS, JANUARY 2021–DECEMBER 2025 208
TABLE 175 MEDTRONIC: COMPANY OVERVIEW 209
TABLE 176 MEDTRONIC: PRODUCTS/SERVICES/SOLUTIONS OFFERED 210
TABLE 177 MEDTRONIC: PRODUCT APPROVALS, JANUARY 2021–DECEMBER 2025 211
TABLE 178 MEDTRONIC: DEALS, JANUARY 2021–DECEMBER 2025 211
TABLE 179 MEDTRONIC: EXPANSIONS, JANUARY 2021–DECEMBER 2025 212
TABLE 180 SMITH+NEPHEW: COMPANY OVERVIEW 214
TABLE 181 SMITH+NEPHEW: PRODUCTS/SERVICES/SOLUTIONS OFFERED 215
TABLE 182 SMITH+NEPHEW: PRODUCT & SERVICE LAUNCHES AND ENHANCEMENTS, JANUARY 2021–DECEMBER 2025 216
TABLE 183 ASENSUS SURGICAL US, INC.: COMPANY OVERVIEW 218
TABLE 184 ASENSUS SURGICAL US, INC.: PRODUCTS/SERVICES/SOLUTIONS OFFERED 219
TABLE 185 ASENSUS SURGICAL US, INC.: PRODUCT APPROVALS,
JANUARY 2021–DECEMBER 2025 219
TABLE 186 ASENSUS SURGICAL US, INC.: DEALS, JANUARY 2021–DECEMBER 2025 220
TABLE 187 SIEMENS HEALTHINEERS AG: COMPANY OVERVIEW 222
TABLE 188 SIEMENS HEALTHINEERS AG: PRODUCTS/SERVICES/SOLUTIONS OFFERED 223
TABLE 189 SIEMENS HEALTHINEERS AG: DEALS, JANUARY 2021–DECEMBER 2025 224
TABLE 190 RENISHAW PLC: COMPANY OVERVIEW 225
TABLE 191 RENISHAW PLC: PRODUCTS/SERVICES/SOLUTIONS OFFERED 226
TABLE 192 RENISHAW PLC: PRODUCT APPROVALS, JANUARY 2021–DECEMBER 2025 227
TABLE 193 GLOBUS MEDICAL: COMPANY OVERVIEW 228
TABLE 194 GLOBUS MEDICAL: PRODUCTS/SERVICES/SOLUTIONS OFFERED 229
TABLE 195 GLOBUS MEDICAL: PRODUCT APPROVALS, JANUARY 2021–DECEMBER 2025 230
TABLE 196 JOHNSON & JOHNSON: COMPANY OVERVIEW 231
TABLE 197 JOHNSON & JOHNSON: PRODUCTS/SERVICES/SOLUTIONS OFFERED 232
TABLE 198 JOHNSON & JOHNSON: PRODUCT APPROVALS, JANUARY 2021–DECEMBER 2025 233
TABLE 199 CMR SURGICAL LTD.: COMPANY OVERVIEW 234
TABLE 200 CMR SURGICAL LTD.: PRODUCTS/SERVICES/SOLUTIONS OFFERED 234
TABLE 201 CMR SURGICAL LTD.: PRODUCT APPROVALS, JANUARY 2021–DECEMBER 2025 235
TABLE 202 CMR SURGICAL LTD.: DEALS, JANUARY 2021–DECEMBER 2025 235
TABLE 203 CMR SURGICAL LTD.: EXPANSIONS, JANUARY 2021–DECEMBER 2025 236
TABLE 204 CMR SURGICAL LTD.: OTHER DEVELOPMENTS, JANUARY 2021–DECEMBER 2025 236
TABLE 205 THINK SURGICAL, INC.: COMPANY OVERVIEW 237
TABLE 206 THINK SURGICAL, INC.: PRODUCTS/SERVICES/SOLUTIONS OFFERED 237
TABLE 207 THINK SURGICAL, INC.: PRODUCT APPROVALS, JANUARY 2021–DECEMBER 2025 238
TABLE 208 THINK SURGICAL, INC.: DEALS, JANUARY 2021–DECEMBER 2025 238
TABLE 209 CORIN GROUP: COMPANY OVERVIEW 240
TABLE 210 CORIN GROUP: PRODUCTS/SERVICES/SOLUTIONS OFFERED 240
TABLE 211 CORIN GROUP: PRODUCT LAUNCHES & APPROVALS,
JANUARY 2021–DECEMBER 2025 241
TABLE 212 MICROSURE: COMPANY OVERVIEW 242
TABLE 213 MICROSURE: PRODUCTS/SERVICES/SOLUTIONS OFFERED 242
TABLE 214 MICROSURE: OTHER DEVELOPMENTS, JANUARY 2021–DECEMBER 2025 243
TABLE 215 AVATERAMEDICAL GMBH: COMPANY OVERVIEW 244
TABLE 216 AVATERAMEDICAL GMBH: PRODUCTS/SERVICES/SOLUTIONS OFFERED 244
TABLE 217 MEDICAL MICROINSTRUMENTS, INC.: COMPANY OVERVIEW 245
TABLE 218 MEDICAL MICROINSTRUMENTS, INC.: PRODUCTS/SERVICES/SOLUTIONS OFFERED 245
TABLE 219 MEDICAL MICROINSTRUMENTS, INC.: PRODUCT APPROVALS,
JANUARY 2021–DECEMBER 2025 245
TABLE 220 MEDICAL MICROINSTRUMENTS, INC.: DEALS, JANUARY 2021–DECEMBER 2025 246
TABLE 221 MEDICAL MICROINSTRUMENTS, INC.: OTHER DEVELOPMENTS,
JANUARY 2021–DECEMBER 2025 246
TABLE 222 MEDICAROID CORPORATION: COMPANY OVERVIEW 247
TABLE 223 MEDICAROID CORPORATION: PRODUCTS/SERVICES/SOLUTIONS OFFERED 247
TABLE 224 MEDICAROID CORPORATION: PRODUCT APPROVALS,
JANUARY 2021–DECEMBER 2025 248
TABLE 225 MEDICAROID CORPORATION: DEALS, JANUARY 2021–DECEMBER 2025 248
TABLE 226 BRAINLAB SE: COMPANY OVERVIEW 249
TABLE 227 BRAINLAB SE: PRODUCTS/SERVICES/SOLUTIONS OFFERED 249
TABLE 228 BRAINLAB SE: PRODUCT APPROVALS, JANUARY 2021–DECEMBER 2025 250
TABLE 229 BRAINLAB SE: DEALS, JANUARY 2021–DECEMBER 2025 250
TABLE 230 ECENTIAL ROBOTICS: COMPANY OVERVIEW 251
TABLE 231 ECENTIAL ROBOTICS: PRODUCTS/SERVICES/SOLUTIONS OFFERED 251
TABLE 232 ECENTIAL ROBOTICS: PRODUCT APPROVALS, JANUARY 2021–DECEMBER 2025 252
TABLE 233 ECENTIAL ROBOTICS: DEALS, JANUARY 2021–DECEMBER 2025 252
TABLE 234 SS INNOVATIONS INTERNATIONAL, INC.: COMPANY OVERVIEW 254
TABLE 235 SS INNOVATIONS INTERNATIONAL, INC.:
PRODUCTS/SERVICES/SOLUTIONS OFFERED 255
TABLE 236 SS INNOVATIONS INTERNATIONAL, INC.:
PRODUCTS/SERVICES/SOLUTIONS IN PIPELINE 257
TABLE 237 SS INNOVATIONS INTERNATIONAL, INC.: PRODUCT LAUNCHES AND APPROVALS, JANUARY 2022–DECEMBER 2025 257
TABLE 238 MONTERIS: COMPANY OVERVIEW 259
TABLE 239 MOMENTIS INNOVATIVE SURGERY: COMPANY OVERVIEW 259
TABLE 240 TINAVI MEDICAL TECHNOLOGIES CO., LTD.: COMPANY OVERVIEW 260
TABLE 241 DISTALMOTION SA: COMPANY OVERVIEW 261
TABLE 242 NOVUS SAĞLIK ÜRÜNLERI AR-GE DANIŞMANLIK (NOVUS ARGE): COMPANY OVERVIEW 262
TABLE 243 SURGICAL ROBOTS MARKET: RESEARCH ASSUMPTIONS 274
TABLE 244 SURGICAL ROBOTS MARKET: RISK ANALYSIS 275

LIST OF FIGURES

FIGURE 1 SURGICAL ROBOTS MARKET SEGMENTATION & REGIONAL SCOPE 27
FIGURE 2 SURGICAL ROBOTS MARKET: YEARS CONSIDERED 28
FIGURE 3 KEY INSIGHTS & MARKET HIGHLIGHTS 31
FIGURE 4 SURGICAL ROBOTS MARKET, BY OFFERING, 2025–2030 (USD MILLION) 32
FIGURE 5 MAJOR STRATEGIES ADOPTED BY KEY PLAYERS IN SURGICAL ROBOTS MARKET 32
FIGURE 6 DISRUPTIVE TRENDS IMPACTING GROWTH OF SURGICAL ROBOTS MARKET 33
FIGURE 7 HIGH-GROWTH SEGMENTS & EMERGING FRONTIERS IN
SURGICAL ROBOTS MARKET (2024) 34
FIGURE 8 ASIA PACIFIC TO REGISTER HIGHEST GROWTH DURING FORECAST PERIOD 35
FIGURE 9 SURGICAL ROBOTS MARKET: DRIVERS, RESTRAINTS,
OPPORTUNITIES, AND CHALLENGES 36
FIGURE 10 SURGICAL ROBOTS MARKET: PORTER’S FIVE FORCES ANALYSIS 48
FIGURE 11 SURGICAL ROBOTS MARKET: SUPPLY CHAIN ANALYSIS 53
FIGURE 12 SURGICAL ROBOTS MARKET: VALUE CHAIN ANALYSIS 54
FIGURE 13 SURGICAL ROBOTS MARKET: ECOSYSTEM ANALYSIS 55
FIGURE 14 TRENDS/DISRUPTIONS IMPACTING CUSTOMER’S BUSINESS IN
SURGICAL ROBOTS MARKET 60
FIGURE 15 INVESTMENT/VENTURE CAPITAL SCENARIO IN SURGICAL ROBOTS MARKET, 2020–2023 (USD BILLION) 61
FIGURE 16 TOP PATENT APPLICANTS/OWNERS (COMPANIES/INSTITUTES) FOR SURGICAL ROBOTS MARKET (JANUARY 2015–OCTOBER 2025) 70
FIGURE 17 TOP PATENT APPLICANT COUNTRIES FOR SURGICAL ROBOTS (JANUARY 2014–DECEMBER 2024) 71
FIGURE 18 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS FOR KEY END USERS 83
FIGURE 19 KEY BUYING CRITERIA FOR TOP TWO END USERS 84
FIGURE 20 SURGICAL ROBOTS MARKET: GEOGRAPHIC SNAPSHOT 119
FIGURE 21 NORTH AMERICA: SURGICAL ROBOTS MARKET SNAPSHOT 121
FIGURE 22 ASIA PACIFIC: SURGICAL ROBOTS MARKET SNAPSHOT 143
FIGURE 23 REVENUE SHARE ANALYSIS OF KEY PLAYERS IN SURGICAL
ROBOTS MARKET (2020−2024) 177
FIGURE 24 MARKET SHARE ANALYSIS OF KEY PLAYERS IN SURGICAL
ROBOTS MARKET (2024) 178
FIGURE 25 SURGICAL ROBOTS MARKET: COMPANY EVALUATION MATRIX
(KEY PLAYERS), 2024 182
FIGURE 26 SURGICAL ROBOTS MARKET: COMPANY FOOTPRINT 183
FIGURE 27 SURGICAL ROBOTS MARKET: COMPANY EVALUATION MATRIX
(STARTUPS/SMES), 2024 189
FIGURE 28 EV/EBITDA OF KEY VENDORS 191
FIGURE 29 YEAR-TO-DATE (YTD) PRICE TOTAL RETURN AND 5-YEAR STOCK BETA
OF KEY VENDORS 191
FIGURE 30 SURGICAL ROBOTS MARKET: BRAND/PRODUCT COMPARATIVE ANALYSIS 192
FIGURE 31 INTUITIVE SURGICAL OPERATIONS, INC.: COMPANY SNAPSHOT 197
FIGURE 32 STRYKER: COMPANY SNAPSHOT 202
FIGURE 33 ZIMMER BIOMET: COMPANY SNAPSHOT 206
FIGURE 34 MEDTRONIC: COMPANY SNAPSHOT 210
FIGURE 35 SMITH+NEPHEW: COMPANY SNAPSHOT 215
FIGURE 36 SIEMENS HEALTHINEERS AG: COMPANY SNAPSHOT 223
FIGURE 37 RENISHAW PLC: COMPANY SNAPSHOT 226
FIGURE 38 GLOBUS MEDICAL: COMPANY SNAPSHOT 229
FIGURE 39 JOHNSON & JOHNSON: COMPANY SNAPSHOT 232
FIGURE 40 SS INNOVATIONS INTERNATIONAL, INC.: COMPANY SNAPSHOT 254
FIGURE 41 SURGICAL ROBOTS MARKET: RESEARCH DESIGN 263
FIGURE 42 SURGICAL ROBOTS MARKET: KEY DATA FROM SECONDARY SOURCES 265
FIGURE 43 SURGICAL ROBOTS MARKET: KEY PRIMARY SOURCES (BY COMPANY TYPE, DESIGNATION, AND REGION) 265
FIGURE 44 SURGICAL ROBOTS MARKET: KEY DATA FROM PRIMARY SOURCES 266
FIGURE 45 SURGICAL ROBOTS MARKET: KEY INDUSTRY INSIGHTS 267
FIGURE 46 SURGICAL ROBOTS MARKET: BOTTOM-UP APPROACH 268
FIGURE 47 SURGICAL ROBOTS MARKET: TOP-DOWN APPROACH 268
FIGURE 48 SUPPLY-SIDE SURGICAL ROBOTS MARKET SIZE ESTIMATION:
REVENUE SHARE ANALYSIS 269
FIGURE 49 SURGICAL ROBOTS MARKET: REVENUE SHARE ANALYSIS
ILLUSTRATION FOR STRYKER 269
FIGURE 50 SUPPLY-SIDE SURGICAL ROBOTS MARKET ESTIMATION (2024) 270
FIGURE 51 SURGICAL ROBOTS MARKET: CAGR PROJECTIONS (SUPPLY-SIDE ANALYSIS) 271
FIGURE 52 SURGICAL ROBOTS MARKET: DATA TRIANGULATION METHODOLOGY 273
FIGURE 53 SURGICAL ROBOTS MARKET: FACTOR ANALYSIS 275

---

---